Stay updated on ATx201 Ointment Safety & Efficacy in AD Clinical Trial
Sign up to get notified when there's something new on the ATx201 Ointment Safety & Efficacy in AD Clinical Trial page.

Latest updates to the ATx201 Ointment Safety & Efficacy in AD Clinical Trial page
- Check4 days agoChange DetectedA banner explaining the NIH transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs no longer appears at the top of the page.SummaryDifference1%

- Check11 days agoChange DetectedThe footer shows an updated ClinicalTrials.gov revision number, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide banner announces changes to NIH websites and explains the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check32 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1; no study information is shown.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page now renders a 403 Forbidden error instead of the full study content, with standard site chrome visible (header/footer and navigation). This indicates a site-level access restriction rather than an update to the trial information.SummaryDifference17%

Stay in the know with updates to ATx201 Ointment Safety & Efficacy in AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATx201 Ointment Safety & Efficacy in AD Clinical Trial page.